跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zidaxim 300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Zidaxim 300
Approved
STANDARD
Zidaxim 300
Hexagon Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
75e1111aff03b7d4
Company
Hexagon Pharmaceuticals
Type
Standard
Approval Details
Approval Id
75e1111aff03b7d4
Drug Approval Philippines Name
Zidaxim 300
Product Name
Zidaxim 300
Registration Number
DRP-551
Brand Name
Zidaxim 300
Generic Name
Ranitidine (as hydrochloride)
Dosage Form
Tablet
Dosage Strength
300 mg
Manufacturer
Hexagon Pharmaceuticals
Importer
Hexagon Pharmaceuticals
Distributor
Hexagon Pharmaceuticals
Issuance Date
27 July 2022
Expiry Date
22 November 2027
Pharmacologic Category
H2-Receptor Antagonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
75e1111aff03b7d4
Type
Standard
Back to Philippines FDA Approvals